+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

From
Lymphedema - Pipeline Insight, 2024 - Product Thumbnail Image

Lymphedema - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Crohns Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Crohns Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 100 Pages
  • Global
From
Dense Deposit Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Dense Deposit Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Seborrhea - Pipeline Insight, 2024 - Product Thumbnail Image

Seborrhea - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Cryoprin-Associated Periodic Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Cryoprin-Associated Periodic Syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Food Allergy - Pipeline Insight, 2024 - Product Thumbnail Image

Food Allergy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Gluten Sensitivity - Pipeline Insight, 2024 - Product Thumbnail Image

Gluten Sensitivity - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Inclusion Body Myositis - Pipeline Insight, 2024 - Product Thumbnail Image

Inclusion Body Myositis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Myofibroblasts - Pipeline Insight, 2024 - Product Thumbnail Image

Myofibroblasts - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Acquired Immunodeficiency Syndrome (AIDS) - Pipeline Insight, 2024 - Product Thumbnail Image

Acquired Immunodeficiency Syndrome (AIDS) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Acute Ocular Pain And Inflammation - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Ocular Pain And Inflammation - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
NETs related disease - Pipeline Insight, 2024 - Product Thumbnail Image

NETs related disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Pollen Allergy - Pipeline Insight, 2024 - Product Thumbnail Image

Pollen Allergy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Polyarticular Juvenile Idiopathic Arthritis - Pipeline Insight, 2024 - Product Thumbnail Image

Polyarticular Juvenile Idiopathic Arthritis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Post-Operative Cataract Surgery Inflammation - Pipeline Insight, 2024 - Product Thumbnail Image

Post-Operative Cataract Surgery Inflammation - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Rabies Immunoglobulins - Pipeline Insight, 2024 - Product Thumbnail Image

Rabies Immunoglobulins - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Radiation Dermatitis - Pipeline Insight, 2024 - Product Thumbnail Image

Radiation Dermatitis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Treg Cell-Based Therapies - Pipeline Insight, 2024 - Product Thumbnail Image

Treg Cell-Based Therapies - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more